INOVIO PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $399.7M | $71.1M |
| FY2022 | — | $222.4M | $46.3M |
| FY2023 | — | $117.3M | $14.3M |
| FY2024 | — | $68.5M | $65.8M |
| FY2025 | — | $24.1M | $44.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $399.7M | $71.1M |
| FY2022 | — | $222.4M | $46.3M |
| FY2023 | — | $117.3M | $14.3M |
| FY2024 | — | $68.5M | $65.8M |
| FY2025 | — | $24.1M | $44.3M |